The Bioequivalence of Two Peficitinib Formulations, and the Effect of Food on the Pharmacokinetics of Peficitinib: Two‐Way Crossover Studies of a Single Dose of 150 mg Peficitinib in Healthy Volunteers

The marketed tablet formulation of peficitinib differs from the tablet used during the clinical trials. The bioequivalence of the marketed formulation and developmental tablet, and the food effect on the marketed formulation, were analyzed in 2 Japanese open‐label, randomized, 2‐way crossover studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Mai, Toyoshima, Junko, Kaneko, Yuichiro, Oda, Kazuo, Kiyota, Tsuyoshi, Kambayashi, Atsushi, Nishimura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984322/
https://www.ncbi.nlm.nih.gov/pubmed/32618438
http://dx.doi.org/10.1002/cpdd.843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984322/
https://www.ncbi.nlm.nih.gov/pubmed/32618438
http://dx.doi.org/10.1002/cpdd.843

Ejemplares similares